GOLDMAN SACHS GROUP INC - KARUNA THERAPEUTICS INC ownership

KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 295 filers reported holding KARUNA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.6%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of KARUNA THERAPEUTICS INC
ValueSharesWeighting
Q4 2023$63,703,904
+968.2%
201,270
+470.7%
0.01%
+1100.0%
Q3 2023$5,963,635
-72.2%
35,269
-64.3%
0.00%
-75.0%
Q2 2023$21,447,332
-28.9%
98,904
-40.5%
0.00%
-42.9%
Q1 2023$30,174,582
-20.3%
166,123
-13.7%
0.01%
-22.2%
Q4 2022$37,837,451
+107564.0%
192,557
+23.2%
0.01%0.0%
Q3 2022$35,144
+48.7%
156,246
-16.4%
0.01%
+50.0%
Q2 2022$23,642
-99.9%
186,877
+23.0%
0.01%
+50.0%
Q1 2022$19,267,000
-18.9%
151,955
-16.2%
0.00%0.0%
Q4 2021$23,745,000
+6.7%
181,263
-0.3%
0.00%0.0%
Q3 2021$22,252,000
+5.6%
181,898
-1.6%
0.00%0.0%
Q2 2021$21,074,000
+9.9%
184,875
+16.0%
0.00%
-20.0%
Q1 2021$19,168,000
+30.6%
159,434
+10.3%
0.01%
+25.0%
Q4 2020$14,682,000
+106.6%
144,516
+57.2%
0.00%
+100.0%
Q3 2020$7,108,000
+83.8%
91,925
+164.9%
0.00%
+100.0%
Q2 2020$3,868,000
+230.6%
34,703
+113.6%
0.00%
Q1 2020$1,170,000
-1.8%
16,244
+2.8%
0.00%
Q4 2019$1,191,000
-22.2%
15,809
-79.3%
0.00%
Q2 2019$1,531,00076,4700.00%
Other shareholders
KARUNA THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Sofinnova Investments, Inc. 1,885,602$135,763,00012.56%
PFM Health Sciences, LP 499,510$35,965,0002.95%
Eventide Asset Management 901,077$64,878,0002.10%
ACUTA CAPITAL PARTNERS, LLC 56,000$4,032,0001.95%
Logos Global Management LP 69,658$5,015,0001.91%
Vivo Capital, LLC 223,692$16,106,0001.46%
Atika Capital Management LLC 90,000$6,480,0001.24%
EAM Global Investors LLC 27,126$1,953,0001.14%
EAM Investors, LLC 40,516$2,917,0000.91%
MOODY ALDRICH PARTNERS LLC 25,844$1,861,0000.56%
View complete list of KARUNA THERAPEUTICS INC shareholders